Project Grant HT94252411073
Award Date
11/1/24
Completion Date
10/31/25
Dollars Obligated
$286K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Lake Mills, WI 53551, USA
Similar Awards
The Defense Health Agency awarded a $899,999 Project Grant to Wake Forest University Health Sciences under the Military Medical Research and Development program (CFDA 12.420) to develop a novel point-of-care assay for monitoring rejection and immunosuppression in vascularized composite allotransplantation (VCA) recipients. The project aims to transform healthcare for service members and the public through innovative biomedical research focused on medical solutions for the battlefield. The...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
The Department of the Army Medical Command awarded a $413,400 Project Grant to Children's Home Healthcare of Cincinnati, OH through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2023 exploring the role of endoplasmic reticulum stress and systemic inflammation in blunt traumatic brain injury-induced optic nerve damage. The Military Medical Research and Development program supports basic, applied, and...
The Department of Defense's Defense Health Agency awarded a $1,158,179.00 Project Grant to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420) to deliver a sustained therapeutic protein cocktail delivery system to prevent vision loss after ocular trauma. The project aims to develop innovative treatments for military service members and veterans by conducting basic, translational, and clinical research. As a sub-award under this grant, the...
The Defense Health Agency awarded a $498,896 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to The Schepens Eye Research Institute, Inc. in Boston, MA. The grant supports a 2-year research project investigating the use of noninvasive transpalpebral electrical stimulation as a therapy for combat-related corneal trauma. As an experienced performer of prior federal grants from agencies like the NIH, DoD, and Army, the non-profit Schepens Eye Research...
The Department of the Army Medical Command awarded Ospedale San Raffaele S.R.L. a $650,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from September 30, 2022 to September 29, 2025 to engineer thymic selection to control the development of alloreactive T cells and promote vascularized composite allograft acceptance. The Military Medical Research and Development program aims to transform military and public health...
The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...
The Defense Health Agency awarded Texas A&M University System Health Science Center a $303,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on Potential-Independent Mitochondrial Targeting from February 15, 2023 through August 31, 2025.
The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative solutions. This award will allow...
The University of Minnesota was awarded a $479,946 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...